Latest Investments News

Fortescue has approved a $3 million exploration budget for Strategic Energy Resources’ Canobie Project, setting the stage for a significant diamond drilling campaign targeting copper-gold mineralisation in northwest Queensland.

Green Technology Metals has achieved a major regulatory milestone by securing full mining lease coverage for its Seymour Lithium Project in Ontario, significantly advancing the project toward construction readiness.

Life360 reported record Q2 2025 results with robust subscription growth and raised full-year guidance, alongside a strategic leadership transition appointing Lauren Antonoff as CEO.

Titan Minerals reports robust drilling results at its Dynasty Gold Project in Ecuador, revealing wide, high-grade gold and silver intercepts that promise resource expansion and improved mine economics.

Platinum Asia Investments Limited (PAI) held a pivotal Scheme Meeting seeking shareholder approval to restructure by exchanging shares for units in the Platinum Asia Fund Complex ETF (PAXX), accompanied by a special dividend payment. The outcome will reshape PAI’s investment management and ownership structure.

Platinum Asia Investments Limited has announced a special dividend of AUD 0.1992 per share, pending court approval and final confirmation post-scheme valuation. The payment is scheduled for September 2025 with a significant franked component.

Kelly Partners Group Holdings posted a robust 24.5% revenue increase to $134.6 million in FY25, driven by strategic international expansions and acquisitions. The firm’s underlying profit after tax also rose 13%, underscoring its growing footprint across Australia, the US, and Ireland.

LGI Limited reported a robust FY25 with 14% EBITDA growth driven by expanded renewable energy capacity and carbon credit sales, while setting ambitious FY26 guidance of 25-30% EBITDA growth.

Platinum Capital Limited has withdrawn its proposed scheme of arrangement due to insufficient shareholder support and is now seeking approval for an on-market buy-back of up to 50% of its shares, aiming to enhance liquidity for investors.

Anteris Technologies reported solid clinical progress with 130 patients implanted with its DurAVR heart valve and is gearing up for its pivotal PARADIGM trial with 79 qualified sites worldwide. The company also strengthened its leadership with two new board members amid ongoing FDA engagement.

LGI Limited reported a robust FY25 with a 13.6% increase in underlying EBITDA to $17.4 million, expanded renewable capacity by 44%, and declared a fully franked dividend. The company’s strategic investments in battery storage and biogas infrastructure position it well in Australia’s energy transition.

Anteris Technologies Global Corp. reported a $42.7 million net loss for the first half of 2025 amid advancing preparations for its pivotal DurAVR Transcatheter Heart Valve trial. The company’s recent IPO proceeds are fueling R&D and manufacturing scale-up as it targets regulatory approvals.